Sight Sciences director and CTO David Badawi sells $70,555 in stock

David Badawi, a key executive at Sight Sciences Inc., divested 7,797 shares of the company's stock on October 1st, 2026. The shares were sold within a price range of $8.87 to $9.25, with an average cost of $9.049 per share, amounting to $70,555. This transaction was primarily to settle tax obligations related to the vesting of restricted stock units.

Following this sale, Badawi now personally owns 1,975,075 shares of Sight Sciences stock, comprising both currently held shares and those set to vest. The company's stock has experienced a remarkable 178% increase over the past year, though its price remains notably erratic. In relation to this sale, Badawi's total shareholding remains substantial, with a majority of shares yet to vest.

Despite this recent sale, Sight Sciences has been demonstrating robust financial health, as evidenced by a 20% rise in second-quarter revenue to $23.4 million and a narrowing of net losses. The company has also raised its revenue projections for the year, signaling optimism about its future performance. Additionally, Sight Sciences has made strategic leadership changes, including the appointment of Kashif Rashid as the new Chief Legal Officer and Corporate Secretary.

These developments collectively underscore Sight Sciences' ongoing growth and transformation. This report, while AI-assisted, has been meticulously reviewed and edited to ensure accuracy and clarity.